Retina Synthesis

147 Avsnitt

1. Genetic Basis of Geographic Atrophy Treatment

   Publicerades: 2021-09-02
2. Dr. Caroline Baumal with brolucizumab safety update.

   Publicerades: 2021-08-16
3. Augmented Reality in Retina

   Publicerades: 2021-08-12
4. Focus on Samuel Barone, MD, CMO with Gemini Therapeutics

   Publicerades: 2021-07-12
5. Protocol W with Dr. Raj Maturi

   Publicerades: 2021-06-15
6. Update on the PANORAMA Trial

   Publicerades: 2021-06-03
7. A New Treatment Paradigm for Diabetic Macular Edema

   Publicerades: 2021-04-27
8. Home OCT Monitoring of Anti-VEGF Therapy of Macular Neovascularization

   Publicerades: 2021-04-15
9. Early Diagnosis of Macular Neovascularization

   Publicerades: 2021-04-06
10. Dr. Diana Do Discusses Kodiak KS-301 for nAMD, DME and RVO

    Publicerades: 2021-04-01
11. Focus on Dr. David Boyer of Retina Vitreous Associates Adjunct Professor, Keck School of Medicine of USC

    Publicerades: 2021-03-07
12. Focus on Cedric Francois, MD, PhD, CEO, Apellis Pharmaceuticals

    Publicerades: 2021-03-07
13. Spotlight on Andrew Moshfeghi, MD, Associate Professor, USC Roski Eye Institute

    Publicerades: 2021-03-07
14. Dr. Charles Wykoff Interviews Karl Csaky MD, PhD Discussing Faricimab for DME and nAMD

    Publicerades: 2021-03-07
15. Focus on Arshad Khanani MD, MA Director of Clinical Services Sierra Eye Associates

    Publicerades: 2021-03-07
16. Dr. Carmen Puliafito Interviews Charles Wykoff MD, PhD: Faricimab Results in DME & nAMD

    Publicerades: 2021-03-07
17. Focus on Carl Regillo, MD, and PDS System

    Publicerades: 2021-03-07
18. Focus on Michael Goldstein , Chief Medical Officer at Ocular Therapeutix

    Publicerades: 2021-03-06
19. Spotlight on David Zacks, M.D., Ph.D. Co-Founder and Chief Science Officer at ONL Therapeutics

    Publicerades: 2021-03-06
20. Focus on Kourous Rezaei Chief Medical Officer at IVERIC bio

    Publicerades: 2021-03-06